SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
A nonprofit community clinic has more than doubled its footprint in Linda Vista following a surge of newly-insured patients. Linda Vista Health Center, part of a seven-clinic umbrella corporation called San Diego Family Care, has added 23,000 square feet to its existing space in a $2.7 million expansion to accommodate the need.May 5, 2016 12:51 p.m. $$ Share
Two San Diego drugmakers reported financial earnings Thursday.
PHARMA: Acadia Prepares To Launch Drug to Treat Parkinson’s Psychosis
Acadia Pharmaceuticals Inc. has earned the greenlight from regulators to sell a valuable antipsychotic drug. The medication, potentially worth billions, quells the hallucinations and delusions experienced by Parkinson’s disease patients. And it’s the first of its kind.
Three public life science firms in San Diego are suffering stock slips after reporting first quarter earnings Wednesday. Two of the firms missed analyst expectations and one exceeded Wall Street’s forecast, but barely.
In a deal worth up to $95 million-plus, San Diego drugmaker Ionis Pharmaceuticals sold global rights to develop and commercialize its marketed drug Kynamro to Chicago-based Kastle Therapeutics.
San Diego’s Illumina Inc. reported quarterly earnings May 3, falling short of analyst expectations and further slipping the company’s stock.
Dexcom Inc., one of San Diego’s biggest public medical technology firms, announced May 2 that it will acquire Nintamed, a distribution partner with presence in Germany, Switzerland and Austria.
Local philanthropists Gary and Mary West have provided $11.8 million to the University of California, San Diego to create a senior emergency care unit at the future Jacobs Medical Center.
MedOptions announced a definitive agreement to acquire San Diego’s Vericare, a behavioral health clinical care provider.
San Diego’s MyDx Inc., a company that makes a handheld chemical analyzer for consumers, announced a jump in quarterly revenue as the startup gains traction.
San Diego-based Biocept Inc. is hoping to raise $5 million in an offering of its common stock, the company announced April 29.
San Diego’s Ignyta Inc., a drugmaker developing cancer therapeutics, is hoping to raise $50 million in an offering of its common stock, the company announced Wednesday.
PHARMA: New Painkiller And Other Drugs Being Tested
It’s been a rocky year for Arena Pharmaceuticals Inc., but things are looking up with its latest experimental drug: a painkiller that mimics cannabis without the head high.
Dexcom Inc., one of San Diego’s biggest public medical technology firms, reported a 60 percent jump in revenue for the first quarter of this year.
San Diego medical device company ResMed Inc. reported a drop in net income for the first quarter of 2016.